Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diagnostic Center) - Global Forecast to 2031

icon1
USD 8.57 BN
MARKET SIZE, 2031
icon2
CAGR 8.9%
(2026-2031)
icon3
289
REPORT PAGES
icon4
316
MARKET TABLES

OVERVIEW

vendor-neutral-archive-VNA-PACS-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global vendor-neutral archive (VNA) & picture archiving and communication systems (PACS) market is projected to grow to USD 8.57 billion by 2031 from USD 5.60 billion in 2026, growing at a CAGR of 8.9%. This growth is driven by the rapid digital transformation of healthcare infrastructure and increasing adoption of cloud-based archiving and AI-enhanced diagnostic tools that support remote workflows and data-driven care.

KEY TAKEAWAYS

  • By Region
    North America accounted for the largest share (42.9%) of the VNA & PACS market in 2025.
  • By Modality
    By modality, the X-ray segment accounted for the largest share (42.8%) of the VNA & PACS market in 2025.
  • By Deployment Model
    The cloud-based deployment models segment is projected to register the highest CAGR (10.4%) from 2026 to 2031.
  • By Product Type
    The VNA segment accounted for the largest market share in 2025.
  • By Vendor Type
    The independent vendors segment accounted for the largest share in 2025
  • By Application
    The cardiology segment accounted for the largest share in 2025.
  • By End User
    The hospital & clinics segment is projected to have the highest CAGR during the study period.

The growth in the medical imaging sector is predominantly fueled by the escalating volume of imaging data and a stronger regulatory push for EHR implementation. Additionally, the ongoing transition towards value-based care is prompting increased investments in scalable and interoperable imaging solutions. Key technological advancements, such as cloud-based storage, Al, and analytics integration, are significantly driving the adoption of VNA and PACS; these innovations facilitate improved clinical workflows, enhance data accessibility, and ultimately lead to better patient care outcomes.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The VNA & PACS market is being significantly disrupted by the convergence of cloud technologies, AI-enabled imaging workflows, and enterprise-wide data interoperability. Traditional siloed PACS are rapidly being replaced by cloud-native VNAs that support both DICOM and non-DICOM formats, enabling unified access across departments and care settings. The growing demand for remote diagnostics, teleradiology, and mobile access is accelerating the need for zero-footprint universal viewers, while rising cybersecurity threats are driving adoption of more secure, scalable, and compliant storage architectures.

vendor-neutral-archive-VNA-PACS-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Heightened investments in medical imaging technologies
  • Growing demand for streamlined healthcare data management solutions
RESTRAINTS
Impact
Level
  • High initial investment for implementing VNA and PACS solutions
  • Lack of standardized protocols and interoperability frameworks
OPPORTUNITIES
Impact
Level
  • Favorable government initiatives for better penetration of AI in medical imaging
  • Increasing medical imaging procedures and large imaging data silos
CHALLENGES
Impact
Level
  • Rising security concerns related to cloud-based image processing and analytics
  • Data security issues in healthcare settings

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Heightened investments in medical imaging technologies

Medical imaging employs various techniques, such as X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), to diagnose illnesses and provide insights into internal bodily conditions. Factors propelling investments in medical imaging technologies include governmental initiatives to modernize imaging facilities and research, the proliferation of diagnostic imaging centers, technological advancements in diagnostic imaging techniques, and patients’ growing preference for minimally invasive treatments

Restraint: High initial investment for implementing VNA and PACS solutions

The significant initial investment required for implementing VNA and PACS solutions poses a notable restraint on the market. Healthcare facilities considering the adoption of VNA and PACS technologies often face substantial upfront costs associated with infrastructure, software licenses, and training. These costs can present a considerable barrier to entry, particularly for smaller healthcare providers or facilities operating on a limited budget.

Opportunity: Favorable government initiatives for better penetration of AI in medical imaging

Innovative solutions, such as AI-based solutions, are used to interpret the massive volume of medical imaging and diagnosis data and transfer it into actionable, useful information that physicians, radiologists, and researchers can use to improve the quality of care. Realizing the benefits of AI-based solutions, government organizations in various countries are increasingly undertaking initiatives to increase the adoption of AI-based technologies in their respective healthcare systems

Challenge: Rising security concerns related to cloud-based image processing and analytics

In spite of the benefits offered by cloud computing, it is associated with several concerns related to integrity, availability, privacy, and confidentiality. Owing to the large number of issues related to cloud data storage, such as data breaches, data theft, and unavailability of cloud data, cloud service providers (CSPs) are required to ensure reliable data services to customers and their stored data. Although cloud computing has certain benefits, many users are still unwilling to store their confidential data in cloud data centers, such as personal health records, diagnostic imaging data, and government-sensitive files. Clients lose direct control over their data sources once the data is stored in a data center. CSPs are continuously striving to ensure data security by using mechanisms such as firewalls and virtualization. These mechanisms, however, cannot entirely provide complete data protection owing to network vulnerabilities and control issues CSPs face regarding cloud applications, hardware, and client data

VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers enterprise imaging solutions with embedded VNA and PACS for multi-department use. Enhances interoperability and reduces data silos across radiology and cardiology systems.
Provides Synapse VNA for centralized archiving of imaging data from disparate systems. Improves data accessibility and long-term storage efficiency, supporting clinical decisions.
Delivers enterprise imaging PACS integrated with VNA for hospitals and imaging centers. Facilitates faster diagnosis and collaboration with unified access to image data.
Supplies scalable PACS and cloud-enabled VNAs for large healthcare networks. Lowers IT overhead while enabling secure, remote access to imaging records.
Offers cloud-based VNA solutions with AI-driven image management. Streamlines workflow and enhances diagnostic accuracy with intelligent data organization.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The VNA & PACS market ecosystem comprises a network of healthcare providers, imaging vendors, cloud service providers, and interoperability standards bodies working together to enable seamless storage, access, and exchange of medical images. Core participants include PACS/VNA software vendors, modality manufacturers (MRI, CT, etc.), cloud infrastructure providers, and cybersecurity firms. Supporting stakeholders like AI-powered imaging analytics companies, teleradiology platforms, and healthcare system integrators further enhances clinical workflows. This interconnected ecosystem is driven by a shared goal of achieving enterprise imaging, cross-vendor compatibility, and improved patient care across regions and healthcare settings.

vendor-neutral-archive-VNA-PACS-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

vendor-neutral-archive-VNA-PACS-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

VNA & PACS Market, By Product Type

In 2025, the VNA segment held the largest share of the VNA & PACS market due to its capability to provide a centralized repository for storing medical images and related metadata in a standardized format, independent of specific imaging modalities or vendors. VNA enables efficient interoperability for data exchange across diverse systems and healthcare facilities, thereby enhancing collaboration and care coordination among providers. The VNA landscape can be delineated into three categories: departmental, multi-department, and multi-site VNA, each tailored to address the specific requirements of various levels within healthcare organizations. These solutions are essential for handling substantial volumes of imaging data, ensuring that medical images are readily accessible across multiple departments, locations, and systems; this access not only streamlines operational workflows but also optimizes patient care delivery. As the healthcare sector increasingly adopts value-based care models, the significance of comprehensive data management solutions, such as VNA, has escalated. Furthermore, VNA empowers healthcare organizations to leverage medical imaging data for initiatives related to population health management, predictive analytics, and personalized medicine. This strategic positioning has established VNA solutions as pivotal contributors to the evolving landscape of medical imaging and healthcare informatics.

VNA & PACS Market, By Deployment Model

The VNA & PACS market is segmented by deployment into cloud-based, on-premises, and hybrid deployment. The cloud-based segment is poised for robust growth throughout the forecast period, driven by a multitude of advantageous factors. Cloud-based VNA and PACS solutions eliminate the necessity for substantial investments in on- premises infrastructure, allowing healthcare organizations to leverage scalable storage and computing resources that can be dynamically configured according to fluctuating demand. This adaptability is particularly critical as healthcare entities grapple with the surging volumes of medical imaging data generated from diagnostic modalities such as X-rays, MRIs, and CT scans. Cloud service providers (CSPs) employ comprehensive security measures-including encryption, stringent access controls, and periodic security audits-to ensure the integrity and confidentiality of patient data. These protocols are essential for meeting regulatory compliance standards such as HIPAA and GDPR, mitigating the risks associated with potential data breaches, which are a major concern for healthcare organizations managing sensitive medical information. In addition, the cost-efficiency of cloud deployment models presents a compelling incentive for organizations aiming to curtail capital expenditures on physical infrastructure while capitalizing on the inherent flexibility of cloud storage solutions. The benefits of remote access and real-time monitoring afforded by cloud-based systems facilitate enhanced collaboration among healthcare professionals, enabling seamless access to imaging data across geographically dispersed locations while ensuring the health and security of the data remain intact.

VNA & PACS Market, By Modality

Based on modality, the VNA & PACS market is segmented into CT, mammography, MRI, ultrasound, X-rays, and PET. The CT segment held the largest market in 2025 due to the growing need for accurate and early diagnosis, advancements in technology, and the digitalization of healthcare. Additionally, CT scans play a crucial role in preventing unnecessary surgeries, improving cancer diagnosis and treatment, and enhancing patient care. Thus, the efficiency, versatility, and effectiveness of CT scans have made them indispensable in modern healthcare, driving their dominance in the VNA & PACS market as the preferred imaging modality for a diverse range of medical applications

VNA & PACS Market, By End User

Based on end-user, the VNA & PACS market is segmented into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and other end users, including research and academic institutes. The hospitals & clinics segment dominates the end-user segment of the VNA & PACS market, as these healthcare facilities generate vast volumes of medical imaging data daily, necessitating robust solutions for managing, storing, and efficiently accessing this data. Moreover, these solutions provide a centralized repository for storing medical images and associated metadata in a standardized format, enabling seamless access and retrieval of patient information across different departments and facilities within hospitals and clinics. Owing to the increasing demand for personalized, data-driven care, the hospitals and clinics segment will remain at the forefront of innovation and investment in VNA and PACS solutions to meet the evolving needs of patients and healthcare professionals alike.

VNA & PACS Market, By Vendor type

Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. Third-party vendors are expected to be the fastest-growing during the forecast period due to their ability to provide flexible, interoperable solutions that integrate across multi-vendor imaging environments. Their offerings often include cost-effective cloud-based storage, enhanced data migration services, and scalable solutions that reduce IT complexity. Additionally, the increasing demand for cross-enterprise data sharing and the shift toward subscription-based models further fuel the growth of third-party VNA & PACS vendors.

VNA & PACS Market, By Application

Based on application, the VNA & PACS market is segmented into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and other applications. The cardiology segment held the largest market share in 2025 due to the high volume of imaging procedures, such as echocardiograms, CT, and MRI scans, which require efficient storage and retrieval systems. The rising prevalence of cardiovascular diseases, growing adoption of advanced imaging technologies for early diagnosis, and increasing integration of AI-driven analytics in cardiac imaging are key drivers supporting the segment's dominance. Moreover, the demand for seamless cross-departmental access to imaging data to support timely interventions in critical care further propels market growth.

REGION

APAC is estimated to register the highest CAGR during the forecast period

The VNA & PACS market in APAC is projected to register the highest CAGR during the forecast period. The growth of this region is due to rising medical imaging investments and technological advancements in diagnostic imaging modalities. Moreover, advancements in technology and the growing prevalence of cloud computing are making VNA and PACS more accessible and affordable in APAC. As healthcare providers in this region continue to prioritize efficiency, accessibility, and quality of care, VNA and PACS solutions will play a pivotal role in driving healthcare transformation and improving patient outcomes across the region.

vendor-neutral-archive-VNA-PACS-market Region

VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX

In the VNA & PACS market matrix, Agfa Healthcare (Star) leads with a strong market presence and comprehensive imaging portfolio, offering interoperable VNA and PACS solutions that support multi-department enterprise imaging across global healthcare networks. Intelerad (Emerging Leader) is rapidly gaining traction with its cloud-native PACS and enterprise imaging platforms, delivering scalable and flexible solutions that appeal to mid-sized and large imaging providers. While Agfa dominates through a broad installed base and end-to-end imaging workflows, Intelerad shows strong momentum to advance toward the leaders' quadrant as cloud adoption and demand for integrated, AI-ready platforms continue to rise.

vendor-neutral-archive-VNA-PACS-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) (Base Year) USD 5.10 BN
Market Size in 2026 (Value) (Estimated Year) USD 5.60 Billion
Market Forecast in 2031 (Value) (Forecast Year) USD 8.57 Billion
CAGR 8.9%
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered USD Billion
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product type: VNA and PACS
  • Modality:
    • CT
    • Mammography
    • MRI
    • Ultrasound
    • X-Rays
    • and PET
  • Deployment Model:
    • On-Premise
    • Cloud-Based
    • and Hybrid Model
  • Vendor type: Independent vendor and Third-party vendor
  • Application:
    • Cardiology
    • Orthopedic
    • Oncology
    • Neurology
    • Obstetrics & Gynecology
    • and others
  • End user:
    • Hospitals & Clinics
    • Diagnostic Centers
    • and others.
Regions Covered North America, Asia Pacific, Europe, the Middle East & Africa, Latin America

WHAT IS IN IT FOR YOU: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE

vendor-neutral-archive-VNA-PACS-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Pricing and distribution channel of VNA & PACS market Delivered detailed analysis of pricing models (subscription, perpetual license, tiered storage) and distribution channels (direct sales, system integrators, cloud marketplaces, and OEM partnerships) Enabled the client to refine their go-to-market strategy and align pricing to competitive and buyer expectations

RECENT DEVELOPMENTS

  • April 2025 : Siemens Healthineers (Germany) and Tower Health (US) unveiled a 10-year value partnership to upgrade imaging systems and digital tools and enhance diagnostic capabilities.
  • March 2025 : GE Healthcare (US) launched the Genesis Cloud Suite, an enterprise imaging SaaS portfolio offering edge, storage, VNA, and data migration solutions to improve workflow efficiency, precision, and IT resource optimization for healthcare providers.
  • March 2025 : FUJIFILM Healthcare Americas (US) partnered with AWS (US) to enhance digital pathology and cloud integration to streamline data lifecycle management and optimize storage of large pathology files within Fujifilm's Synapse Pathology platform.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
32
EXECUTIVE SUMMARY
48
PREMIUM INSIGHTS
53
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Heightened investments in medical imaging technologies
    - Growing demand for streamlined healthcare data management solutions
    - Integration of PACS/VNA with electronic medical records
    RESTRAINTS
    - High initial investment for implementing VNA and PACS solutions
    - Lack of standardized protocols and interoperability frameworks
    OPPORTUNITIES
    - Favorable government initiatives for better penetration of Al in medical imaging
    - Increasing medical imaging procedures and large imaging data silos
    - Rapid uptake of big data in healthcare
    CHALLENGES
    - Rising security concerns related to cloud-based image processing and analytics
    - Data security issues in healthcare settings
  • 5.3 INDUSTRY TRENDS
    CLOUD ADOPTION
    AI AND ML INTEGRATION
    VALUE-BASED CARE MODELS
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Digital imaging and communications in medicine (DICOM)
    - Enterprise imaging solutions
    - Cloud-based storage and services
    COMPLEMENTARY TECHNOLOGIES
    - Image exchange networks
    - Data analytics and business intelligence
    ADJACENT TECHNOLOGIES
    - Health information exchange (HIE)
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.11 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.12 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF VNA & PACS SOLUTIONS, BY PRODUCT TYPE, 2024
    AVERAGE SELLING PRICE OF VNA & PACS SOLUTIONS, BY REGION (QUALITATIVE)
  • 5.13 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
  • 5.14 PATENT ANALYSIS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    LIST OF MAJOR PATENTS, 2020–2024
  • 5.15 CASE STUDY ANALYSIS
    AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL MEDICAL IMAGING PLATFORM GROWTH
    NHS TRUST ADOPTED INSTANT DATA ACCESS VNA TO ESTABLISH UNIFIED PLATFORM FOR DICOM IMAGE DATA STORAGE AND MANAGEMENT
  • 5.16 UNMET NEEDS & END-USER EXPECTATIONS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.17 BUSINESS MODELS
    ENTERPRISE LICENSING MODELS
    SOFTWARE-AS-A-SERVICE (SAAS) MODELS
    PAY-PER-USE MODELS
    HYBRID MODELS
  • 5.18 IMPACT OF 2025 US TARIFF ON VNA & PACS MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - North America
    - Europe
    - Asia Pacific
    IMPACT ON END-USE INDUSTRIES
    - Hospitals & clinics
    - Diagnostics centers
    - Ambulatory surgery centers
    - Other end users
    CONCLUSION
VNA & PACS MARKET, BY MODALITY
88
  • 6.1 INTRODUCTION
  • 6.2 CT
    GROWING NEED FOR IMAGING MODALITIES IN MEDICAL FIELDS TO SUPPORT MARKET GROWTH
  • 6.3 MAMMOGRAPHY
    RISING INCIDENCE OF BREAST CANCER TO PROPEL MARKET GROWTH
  • 6.4 ULTRASOUND
    TECHNOLOGICAL ADVANCEMENTS IN ULTRASOUND DEVICES TO AID MARKET GROWTH
  • 6.5 MRI
    COST-EFFECTIVENESS AND EASY AVAILABILITY IN SMALL HEALTHCARE FACILITIES TO FUEL MARKET ADOPTION
  • 6.6 X-RAY
    DEVELOPMENTS IN X-RAY IMAGING TO BOOST ADOPTION OF VNA AND PACS SOLUTIONS
  • 6.7 PET
    NEED FOR BETTER MANAGEMENT AND STORAGE OF LARGE DATA VOLUMES TO FAVOR MARKET GROWTH
VNA & PACS MARKET, BY DEPLOYMENT MODEL
97
  • 7.1 INTRODUCTION
  • 7.2 ON-PREMISES DEPLOYMENT MODELS
    BETTER CONTROL AND SECURITY FOR SENSITIVE PATIENT DATA TO AUGMENT MARKET GROWTH
  • 7.3 CLOUD-BASED DEPLOYMENT MODELS
    TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET
  • 7.4 HYBRID DEPLOYMENT MODELS
    GREATER FLEXIBILITY, SCALABILITY, AND CONTROL OVER DATA MANAGEMENT STRATEGIES TO PROPEL MARKET GROWTH
VNA & PACS MARKET, BY PRODUCT TYPE
103
  • 8.1 INTRODUCTION
  • 8.2 VNA
    DEPARTMENT VNA
    - Limitations in addressing scalability and interoperability across diverse departments to hinder market growth
    MULTI-DEPARTMENT VNA
    - Multi-department VNA to streamline data management processes and reduce redundancies
    MULTI-SITE VNA
    - Multi-site VNA to provide centralized repository for managing medical data and standardizing medical records
  • 8.3 PACS
    DEPARTMENT PACS
    - Need for better medical imaging data storage to aid market growth
    MULTI-DEPARTMENT PACS
    - Technological advancements in multi-department PACS to improve image retrieval speed and ensure data integrity
    MULTI-SITE PACS
    - Advancements in cloud-based PACS solutions to propel market growth
VNA & PACS MARKET, BY VENDOR TYPE
113
  • 9.1 INTRODUCTION
  • 9.2 INDEPENDENT VENDORS
    INCREASED FLEXIBILITY, BETTER INTEROPERABILITY, AND IMPROVED SOLUTIONS TO DRIVE MARKET
  • 9.3 THIRD-PARTY VENDORS
    NEED FOR INNOVATIVE SOLUTIONS TO DRIVE THIRD-PARTY VENDOR PRESENCE
VNA & PACS MARKET, BY APPLICATION
118
  • 10.1 INTRODUCTION
  • 10.2 CARDIOLOGY
    RISING CASES OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 10.3 ORTHOPEDIC
    GROWING VOLUME AND COMPLEXITY OF ORTHOPEDIC MEDICAL IMAGING SCANS TO PROPEL MARKET GROWTH
  • 10.4 ONCOLOGY
    RISING NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
  • 10.5 NEUROLOGY
    INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
  • 10.6 OBSTETRICS & GYNECOLOGY
    USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE MARKET
  • 10.7 OTHER APPLICATIONS
VNA & PACS MARKET, BY END USER
126
  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS & CLINICS
    NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
  • 11.3 DIAGNOSTIC CENTERS
    LACK OF ADVANCED IMAGING MODALITIES IN SMALL AND MID-SCALE HOSPITALS TO AUGMENT MARKET GROWTH
  • 11.4 AMBULATORY SURGERY CENTERS
    INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT MARKET GROWTH
  • 11.5 OTHER END USERS
VNA & PACS MARKET, BY REGION
132
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate global VNA & PACS market during study period
    CANADA
    - Rising cases of end-stage kidney diseases to propel market growth
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing number of MRI units and diagnostic imaging centers to drive market
    UK
    - Rising funding and investments in diagnostic imaging to support market growth
    FRANCE
    - Rising target patient population and increasing government-funded investments to fuel uptake of VNA and PACS solutions
    ITALY
    - Established healthcare infrastructure to aid market growth
    SPAIN
    - Growing access to advanced cancer diagnostics to propel market
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Presence of universal healthcare coverage to fuel market
    CHINA
    - Strong government support for healthcare reforms and increased number of medical imaging procedures to drive market
    INDIA
    - Improving healthcare infrastructure and increasing private-public partnerships to support market growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Presence of free and universal healthcare system to propel market growth
    MEXICO
    - Rapid technological advancements in imaging solutions to support market growth
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Technological integration to spur inclusivity, accessibility, affordability, and growth in healthcare sector
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
211
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VNA & PACS MARKET
  • 13.3 REVENUE ANALYSIS, 2020–2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Product type footprint
    - Deployment model footprint
    - End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SME players
    - Competitive benchmarking of startups/SME players
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 13.8 BRAND/SOFTWARE COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
232
  • 14.1 KEY COMPANIES
    AGFA-GEVAERT GROUP
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    SECTRA AB
    - Business overview
    - Solutions offered
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    MERATIVE
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Solutions offered
    - Recent developments
    CANON MEDICAL SYSTEMS CORPORATION
    - Business overview
    - Solutions offered
    - Recent developments
    INTELERAD. INTELERAD.
    - Business overview
    - Solutions offered
    - Recent developments
    PAXERAHEALTH
    - Business overview
    - Solutions offered
    NOVARAD CORPORATION
    - Business overview
    - Solutions offered
    HYLAND SOFTWARE, INC.
    - Business overview
    - Solutions offered
    - Recent developments
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Solutions offered
    - Recent developments
    BRIDGEHEAD SOFTWARE LTD.
    - Business overview
    - Solutions offered
    - Recent developments
    CANOPY PARTNERS
    - Business overview
    - Solutions offered
    CRELIOHEALTH INC.
    - Business overview
    - Solutions offered
    ASPYRA, LLC
    - Business overview
    - Solutions offered
    POSTDICOM
    - Business overview
    - Solutions offered
    MEDICASOFT
    - Business overview
    - Solutions offered
    ESAOTE S.P.A.
    - Business overview
    - Solutions offered
    - Recent developments
    VISUS HEALTH IT GMBH
    - Business overview
    - Solutions offered
  • 14.2 OTHER PLAYERS
    ADVAHEALTH SOLUTIONS
    SOFTTEAM SOLUTIONS PVT. LTD.
    ARO SYSTEMS
    CENTRAL DATA NETWORKS
    ONEPACS
    DEDALUS S.P.A.
APPENDIX
279
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 VNA & PACS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 VNA & PACS MARKET: FACTOR ANALYSIS
  • TABLE 3 VNA & PACS MARKET: STUDY ASSUMPTIONS
  • TABLE 4 VNA & PACS MARKET: RISK ANALYSIS
  • TABLE 5 VNA & PACS MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 VNA & PACS MARKET: PORTER’S FIVE FORCES
  • TABLE 7 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
  • TABLE 8 KEY BUYING CRITERIA FOR MAJOR END USERS
  • TABLE 9 VNA & PACS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 10 AVERAGE SELLING PRICE OF PACS SOLUTIONS, BY PRODUCT TYPE, 2024
  • TABLE 11 AVERAGE SELLING PRICE OF VNA SOLUTIONS, BY PRODUCT TYPE, 2024
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR VNA & PACS SOLUTIONS
  • TABLE 17 VNA & PACS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2024
  • TABLE 18 CASE STUDY 1: AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL MEDICAL IMAGING PLATFORM GROWTH
  • TABLE 19 CASE STUDY 2: NHS TRUST ADOPTED INSTANT DATA ACCESS TO ESTABLISH UNIFIED PLATFORM FOR DICOM IMAGE DATA STORAGE AND MANAGEMENT
  • TABLE 20 VNA & PACS MARKET: UNMET NEEDS
  • TABLE 21 VNA & PACS MARKET: END-USER EXPECTATIONS
  • TABLE 22 VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 23 VNA & PACS MARKET FOR CT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 24 VNA & PACS MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 25 VNA & PACS MARKET FOR ULTRASOUND, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 26 VNA & PACS MARKET FOR MRI, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 27 VNA & PACS MARKET FOR X-RAY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 28 VNA & PACS MARKET FOR PET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 30 VNA & PACS MARKET FOR ON-PREMISES DEPLOYMENT MODELS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 31 VNA & PACS MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 VNA & PACS MARKET FOR HYBRID DEPLOYMENT MODELS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 34 VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 35 VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 DEPARTMENT VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 MULTI-DEPARTMENT VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 MULTI-SITE VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 40 PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 DEPARTMENT PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 MULTI-DEPARTMENT PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 MULTI-SITE PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 45 KEY INDEPENDENT VENDORS OPERATING IN MARKET
  • TABLE 46 VNA & PACS MARKET FOR INDEPENDENT VENDORS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 KEY THIRD-PARTY VENDORS OPERATING IN MARKET
  • TABLE 48 VNA & PACS MARKET FOR THIRD-PARTY VENDORS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 50 VNA & PACS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 VNA & PACS MARKET FOR ORTHOPEDIC, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 VNA & PACS MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 VNA & PACS MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 VNA & PACS MARKET FOR OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 VNA & PACS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 56 VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 57 VNA & PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 VNA & PACS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 VNA & PACS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 VNA & PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 VNA & PACS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 71 US: KEY MACROINDICATORS
  • TABLE 72 US: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 73 US: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 74 US: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 75 US: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 76 US: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 77 US: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 78 US: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 79 US: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 80 CANADA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 81 CANADA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 82 CANADA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 83 CANADA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 84 CANADA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 85 CANADA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 86 CANADA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 87 CANADA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 88 EUROPE: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 EUROPE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 90 EUROPE: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 91 EUROPE: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 92 EUROPE: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 93 EUROPE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 94 EUROPE: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 95 EUROPE: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 96 EUROPE: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 97 GERMANY: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 GERMANY: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 99 GERMANY: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 100 GERMANY: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 101 GERMANY: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 102 GERMANY: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 103 GERMANY: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 104 GERMANY: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 105 UK: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 UK: VNA MARKET, BY TYPE 2023–2030 (USD MILLION)
  • TABLE 107 UK: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 108 UK: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 109 UK: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 110 UK: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 111 UK: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 112 UK: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 113 FRANCE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 FRANCE: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 115 FRANCE: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 116 FRANCE: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 117 FRANCE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 118 FRANCE: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 FRANCE: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 120 FRANCE: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 121 ITALY: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 122 ITALY: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 123 ITALY: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 124 ITALY: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 125 ITALY: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 126 ITALY: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 127 ITALY: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 128 ITALY: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 129 SPAIN: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 130 SPAIN: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 131 SPAIN: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 SPAIN: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 133 SPAIN: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 134 SPAIN: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 135 SPAIN: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 136 SPAIN: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 143 REST OF EUROPE: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE,2023–2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 154 JAPAN: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 155 JAPAN: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 156 JAPAN: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 157 JAPAN: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 158 JAPAN: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 159 JAPAN: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 JAPAN: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 161 JAPAN: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 162 CHINA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 163 CHINA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 CHINA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 165 CHINA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 166 CHINA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 167 CHINA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 CHINA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 169 CHINA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 170 INDIA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 171 INDIA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 172 INDIA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 INDIA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 174 INDIA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 175 INDIA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 INDIA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 177 INDIA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 194 LATIN AMERICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 195 BRAZIL: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 BRAZIL: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 BRAZIL: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 BRAZIL: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 199 BRAZIL: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 200 BRAZIL: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 201 BRAZIL: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 202 BRAZIL: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 203 MEXICO: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 MEXICO: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 MEXICO: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 MEXICO: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 207 MEXICO: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 208 MEXICO: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 209 MEXICO: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 210 MEXICO: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 REST OF LATIN AMERICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 215 REST OF LATIN AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 216 REST OF LATIN AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 217 REST OF LATIN AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 218 REST OF LATIN AMERICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 231 GCC COUNTRIES: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 232 GCC COUNTRIES: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 236 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 237 REST OF MIDDLE EAST & AFRICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 REST OF MIDDLE EAST & AFRICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 239 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 240 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 241 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 242 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 243 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 244 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VNA & PACS MARKET, JANUARY 2022–MAY 2025
  • TABLE 245 VNA & PACS MARKET: DEGREE OF COMPETITION
  • TABLE 246 VNA & PACS MARKET: REGION FOOTPRINT
  • TABLE 247 VNA & PACS MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 248 VNA & PACS MARKET: DEPLOYMENT MODEL FOOTPRINT
  • TABLE 249 VNA & PACS MARKET: END-USER FOOTPRINT
  • TABLE 250 VNA & PACS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 251 VNA & PACS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
  • TABLE 252 VNA & PACS MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 253 VNA & PACS MARKET: DEALS, JANUARY 2022–MAY 2025
  • TABLE 254 VNA & PACS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 255 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
  • TABLE 256 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
  • TABLE 257 AGFA-GEVAERT GROUP: DEALS, JANUARY 2022–MAY 2025
  • TABLE 258 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 259 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
  • TABLE 260 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–MAY 2025
  • TABLE 261 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 262 SECTRA AB: COMPANY OVERVIEW
  • TABLE 263 SECTRA AB: SOLUTIONS OFFERED
  • TABLE 264 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 265 GE HEALTHCARE: SOLUTIONS OFFERED
  • TABLE 266 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 267 GE HEALTHCARE: DEALS, JANUARY 2022–MAY 2025
  • TABLE 268 MERATIVE: COMPANY OVERVIEW
  • TABLE 269 MERATIVE: SOLUTIONS OFFERED
  • TABLE 270 MERATIVE: DEALS, JANUARY 2022–MAY 2025
  • TABLE 271 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 272 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
  • TABLE 273 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 274 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 275 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 276 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
  • TABLE 277 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–MAY 2025
  • TABLE 278 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 279 INTELERAD. INTELERAD.: COMPANY OVERVIEW
  • TABLE 280 INTELERAD. INTELERAD.: SOLUTIONS OFFERED
  • TABLE 281 INTELERAD. INTELERAD.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 282 INTELERAD. INTELERAD.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 283 PAXERAHEALTH: COMPANY OVERVIEW
  • TABLE 284 PAXERAHEALTH: SOLUTIONS OFFERED
  • TABLE 285 NOVARAD CORPORATION: COMPANY OVERVIEW
  • TABLE 286 NOVARAD CORPORATION: SOLUTIONS OFFERED
  • TABLE 287 HYLAND SOFTWARE, INC.: COMPANY OVERVIEW
  • TABLE 288 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
  • TABLE 289 HYLAND SOFTWARE, INC.:DEALS, JANUARY 2022–MAY 2025
  • TABLE 290 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 291 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED
  • TABLE 292 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–MAY 2025
  • TABLE 293 BRIDGEHEAD SOFTWARE LTD.: COMPANY OVERVIEW
  • TABLE 294 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
  • TABLE 295 BRIDGEHEAD SOFTWARE LTD.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 296 CANOPY PARTNERS: COMPANY OVERVIEW
  • TABLE 297 CANOPY PARTNERS: SOLUTIONS OFFERED
  • TABLE 298 CRELIOHEALTH INC.: COMPANY OVERVIEW
  • TABLE 299 CRELIOHEALTH INC.: SOLUTIONS OFFERED
  • TABLE 300 ASPYRA, LLC: COMPANY OVERVIEW
  • TABLE 301 ASPYRA, LLC: SOLUTIONS OFFERED
  • TABLE 302 POSTDICOM: COMPANY OVERVIEW
  • TABLE 303 POSTDICOM: SOLUTIONS OFFERED
  • TABLE 304 MEDICASOFT: COMPANY OVERVIEW
  • TABLE 305 MEDICASOFT: SOLUTIONS OFFERED
  • TABLE 306 ESAOTE S.P.A.: COMPANY OVERVIEW
  • TABLE 307 ESAOTE S.P.A.: SOLUTIONS OFFERED
  • TABLE 308 ESAOTE S.P.A.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 309 VISUS HEALTH IT GMBH: COMPANY OVERVIEW
  • TABLE 310 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED
  • TABLE 311 ADVAHEALTH SOLUTIONS: COMPANY OVERVIEW
  • TABLE 312 SOFTTEAM SOLUTIONS PVT. LTD.: COMPANY OVERVIEW
  • TABLE 313 ARO SYSTEMS: COMPANY OVERVIEW
  • TABLE 314 CENTRA DATA NETWORKS: COMPANY OVERVIEW
  • TABLE 315 ONEPACS: COMPANY OVERVIEW
  • TABLE 316 DEDALUS S.P.A.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 VNA & PACS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 VNA & PACS MARKET: YEARS CONSIDERED
  • FIGURE 3 VNA & PACS MARKET: RESEARCH DESIGN
  • FIGURE 4 VNA & PACS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 VNA & PACS MARKET: PRIMARY SOURCES
  • FIGURE 6 VNA & PACS MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 VNA & PACS MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 11 VNA & PACS MARKET: BOTTOM-UP APPROACH
  • FIGURE 12 VNA & PACS MARKET: TOP-DOWN APPROACH
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VNA & PACS MARKET
  • FIGURE 14 VNA & PACS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
  • FIGURE 15 VNA & PACS MARKET: DATA TRIANGULATION
  • FIGURE 16 VNA & PACS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 VNA & PACS MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 VNA & PACS MARKET, BY VENDOR TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 VNA & PACS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 VNA & PACS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 VNA & PACS MARKET: REGIONAL SNAPSHOT
  • FIGURE 23 NEED TO HANDLE GROWING DATA VOLUME TO FUEL DEMAND FOR VNA AND PACS SOLUTIONS
  • FIGURE 24 JAPAN AND VNA ACCOUNTED FOR SIGNIFICANT MARKET SHARE IN 2024
  • FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 26 ASIA PACIFIC TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 28 VNA & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 VNA & PACS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 30 VNA & PACS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 31 VNA & PACS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 VNA & PACS MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024
  • FIGURE 33 VNA & PACS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
  • FIGURE 35 KEY BUYING CRITERIA FOR MAJOR END USERS
  • FIGURE 36 JURISDICTION AND TOP APPLICANT ANALYSIS IN VNA & PACS MARKET, JANUARY 2022–MAY 2025
  • FIGURE 37 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR VNA & PACS SOLUTIONS (JANUARY 2015–MAY 2025)
  • FIGURE 38 NORTH AMERICA: VNA & PACS MARKET SNAPSHOT
  • FIGURE 39 UK: NUMBER OF MEDICAL IMAGING UNDER NATIONAL HEALTH SERVICE (NHS), JANUARY 2022–JANUARY 2023
  • FIGURE 40 ASIA PACIFIC: VNA & PACS MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN VNA & PACS MARKET, 2020–2024 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VNA & PACS MARKET (2024)
  • FIGURE 43 VNA & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 VNA & PACS MARKET: COMPANY FOOTPRINT
  • FIGURE 45 VNA & PACS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS
  • FIGURE 48 VNA & PACS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 49 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
  • FIGURE 50 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 SECTRA AB: COMPANY SNAPSHOT
  • FIGURE 52 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 54 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 55 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT

 

Methodology

The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

BREAKDOWN OF PRIMARIES

Vendor Neutral Archive (VNA) & PACS Market
 Size, and Share

Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.

Vendor Neutral Archive (VNA) & PACS Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.

Market Definition

VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.

Key Stakeholders

  • VNA & PACS vendors
  • Government bodies
  • Healthcare service providers
  • Clinical/Physician centers
  • Healthcare professionals
  • Health IT service providers
  • Healthcare associations/institutes
  • Ambulatory care centers
  • Venture capitalists
  • Distributors and resellers
  • Maintenance and support service providers
  • Integration service providers
  • Healthcare players

Report Objectives

  • To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
  • To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries

 

Key Questions Addressed by the Report

What is the current market valuation and the projected growth trajectory for the VNA and PACS industry through 2030?

The global vendor-neutral archive (VNA) and PACS market is valued at approximately USD 5.10 billion in 2025 and is forecasted to reach USD 7.92 billion by 2030, progressing at a CAGR of 9.2%. This growth is underpinned by the massive influx of diagnostic imaging data and a systemic shift toward enterprise-wide imaging strategies. For C-level stakeholders, this represents a critical transition from siloed departmental storage to integrated, longitudinal patient imaging records that drive clinical efficiency.

How are cloud-native architectures and AI integration disrupting traditional medical imaging workflows?

Cloud-based deployment is the fastest-growing segment, projected to expand at a CAGR of 10.8% as healthcare providers seek to reduce on-premise hardware overhead and improve remote accessibility for teleradiology. Furthermore, the integration of AI-assisted diagnostic tools within VNAs is transforming the archive from a passive storage bin into an active clinical decision support engine. This synergy allows for automated triaging and incidental finding detection, significantly shortening the diagnostic lifecycle and enhancing provider productivity.

What are the primary revenue growth strategies for vendors operating in this increasingly commoditized market?

To combat the commoditization of basic storage, leading vendors are shifting their focus toward high-margin value-added services, such as advanced lifecycle management, cybersecurity-as-a-service, and cross-platform interoperability modules. Strategic differentiation now lies in offering "zero-footprint" universal viewers and specialized modules for high-growth modalities like PET and digital pathology. By prioritizing recurring revenue models through SaaS and managed services, vendors can secure long-term client retention while expanding their footprint within large integrated delivery networks (IDNs).

What specific market opportunities exist within the transition from departmental PACS to enterprise-wide VNA systems?

The primary opportunity lies in "de-coupling" imaging data from proprietary hardware, allowing healthcare systems to achieve true vendor neutrality and avoid expensive data migration during hardware refreshes. As hospitals consolidate, the demand for a centralized clinical repository that supports both DICOM and non-DICOM data (such as pathology slides and surgical videos) is surging. Capturing this "enterprise imaging" segment is vital, as it positions a vendor as the foundational data layer for the entire healthcare organization’s diagnostic ecosystem.

How do regulatory frameworks and data security standards influence the adoption of next-generation VNA solutions?

Compliance with stringent regulations like HIPAA, GDPR, and the HITECH Act is no longer optional; it is a primary market driver. Modern VNAs are designed with robust encryption and audit trails to mitigate the rising risk of ransomware and data breaches, which remain a top concern for CIOs. Strategic adoption is often triggered by the need to meet these regulatory mandates for data interoperability and patient data rights, ensuring that imaging assets remain secure, accessible, and compliant throughout their multi-decadal lifecycle.

What are the most significant challenges and risks associated with implementing large-scale VNA and PACS migrations?

The most formidable barriers remain the high upfront capital expenditure and the technical complexity of migrating petabytes of legacy data without disrupting active clinical workflows. Organizations often face "vendor lock-in" risks where proprietary tags in legacy PACS complicate the transition to a neutral archive. Moreover, the lack of standardized terminology across different medical specialties can lead to data fragmentation, requiring sophisticated "data cleansing" and mapping services to ensure clinical accuracy during the consolidation process.

Which regional insights should global players prioritize for their expansion and investment roadmaps?

North America currently commands a dominant 42.8% market share, driven by rapid digital transformation and high healthcare IT spending in the United States. However, the Asia-Pacific region is identified as the fastest-growing frontier due to government-led healthcare infrastructure modernization and a massive increase in diagnostic volumes in China and India. For global enterprises, North America offers stability and high-value AI integration opportunities, while the APAC region represents a high-volume growth opportunity for scalable, cost-effective cloud solutions.

Who are the key players in the competitive landscape, and what is the "right to win" in this sector?

The market is led by diversified giants such as GE HealthCare, Siemens Healthineers, Philips, and FUJIFILM, alongside specialized players like Hyland, Agfa HealthCare, and Sectra. The "right to win" in this sector is increasingly determined by a vendor’s ability to provide a "single source of truth" for all clinical media. Companies that successfully bridge the gap between radiology, cardiology, and emerging digital pathology workflows through interoperable, AI-ready platforms will capture the largest share of future enterprise imaging contracts.

Growth Signals

See competitors, opportunities & growth signals

Explore Intelligence

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vendor Neutral Archive (VNA) & PACS Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Vendor Neutral Archive (VNA) & PACS Market

Marcus

Apr, 2026

As a healthcare IT professional, how can VNA and PACS integration be optimized for better interoperability and imaging workflow efficiency?.

Carlos

Apr, 2026

How is VNA configuration and system integration improving data accessibility and imaging management across healthcare networks?.

Griffin

Apr, 2026

How can hospitals effectively integrate radiology and cardiology PACS systems for improved imaging workflow and interoperability?.

Blake

Apr, 2026

How are third-party VNA providers and AI integration improving medical imaging data management and accessibility?.

Jordan

Apr, 2026

How are cloud-based VNA systems improving workflow integration, data storage, and interoperability in healthcare imaging?.

Ethan

Apr, 2026

How are healthcare organizations differentiating between VNA and PACS, and what are the key benefits of each system in imaging workflows?.

Mason

Apr, 2026

From a hospital IT standpoint, what are the biggest barriers to adopting Vendor Neutral Archive (VNA) solutions alongside legacy PACS systems?.

Logan

Apr, 2026

How do you evaluate the ROI of implementing a VNA, especially for mid-sized healthcare providers with limited budgets?.

Carter

Apr, 2026

Do you see scalability challenges as imaging volumes grow with AI-driven diagnostics and multi-modality imaging?.

Avery

Apr, 2026

How confident can healthcare organizations be about data security and compliance when shifting to VNA, particularly in cloud deployments?.

Harper

Apr, 2026

What future opportunities do you see emerging in the VNA/PACS market as healthcare becomes more data-driven?.

Show More
What the Report Didn't Show You? Turn research into consulting-grade strategic intelligence.
15+ outputs | Interactive dashboards | Proprietary data
Explore with GrowthIQ →
DMCA.com Protection Status